- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: RC48-ADC 2.5 mg/kg (HER2 Positive)
Total 179 results
-
National Cancer Institute, EgyptCompleted
-
Medical College of WisconsinRecruitingB-cell Lymphoma | Burkitt LymphomaUnited States
-
Hoffmann-La RocheGilead Sciences, Inc., GlaxoSmithKline plc, Seattle Genetics and AstellasRecruitingBladder Cancer | Urothelial CarcinomaUnited States, Spain, Korea, Republic of, United Kingdom, Taiwan, France, Greece
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited Kingdom, United States, Israel, Spain, Italy, Czechia, Canada, Hungary, Poland, Russian Federation, Brazil, Ukraine
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLCRecruitingMetastatic Pancreatic CancerUnited States
-
Colette ShenAstraZeneca; University of North Carolina, Chapel HillRecruitingBreast Cancer | Brain Metastases, AdultUnited States
-
Fundacion para la Investigacion Biomedica del Hospital...University of Alcala; Hospital Universitario Ramon y Cajal; Instituto de Salud... and other collaboratorsRecruitingPolycystic Ovary Syndrome | Hyperandrogenism | Type 1 Diabetes | Hirsutism | Oligomenorrhea | Ovulation DisorderSpain
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Canada
-
New York Institute of TechnologyStony Brook UniversityUnknown
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CelltrionRecruitingBowel Disease | Inflammatory Disease | Disease CrohnNetherlands
-
Grupo Español de Investigación en Cáncer de OvarioGlaxoSmithKline; Hoffmann-La Roche; Apices Soluciones S.L.; AGO Study Group; ARCAGY... and other collaboratorsActive, not recruitingRecurrent Ovarian CarcinomaFrance, Spain, Belgium, Italy, Germany
-
Hoffmann-La RocheFoundation Medicine, Inc.Active, not recruitingCancer of Unknown Primary SiteUnited Kingdom, Korea, Republic of, France, Australia, Germany, Austria, Croatia, Denmark, Finland, Greece, Hungary, Italy, Portugal, Spain, Japan, Brazil, Colombia, Mexico, Romania, Czechia, Norway, Thailand, Switzerland, Turkey, Nethe... and more
-
Seoul National University Bundang HospitalRoche Pharma AG; Korean Cancer Study GroupRecruitingSolid Tumor | Metastatic Cancer | Advanced Solid TumorKorea, Republic of
-
Ramathibodi HospitalCompletedRadical MastectomyThailand
-
National Research Center for Hematology, RussiaRecruitingPrimary Mediastinal LymphomaRussian Federation
-
National Cancer Institute (NCI)CompletedMetastatic OsteosarcomaUnited States
-
Medical University of WarsawHuman Biome Institute S.A.Active, not recruitingParkinson DiseasePoland
-
TASK Applied ScienceCompletedPulmonary TuberculosisSouth Africa
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Kidney Medullary Carcinoma | SMARCB1 NegativeUnited States
-
Duke UniversityTerminatedLaparoscopic Colorectal ResectionUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditionsUnited States, Puerto Rico
-
UNICANCERAstraZeneca; Fondation ARCActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic AdenocarcinomaUnited States, Israel, Canada
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
National Cancer Institute (NCI)RecruitingRenal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Sporadic Papillary Renal Cell CarcinomaUnited States